Introduction
Cancer Center, 110 East Warren Avenue, Detroit, MI 48201, USA 3 Dr Yuli Wu and Dr Nandita Barnabas have equally contributed to the The etiology of breast cancer, the most frequent malignancy content of this paper diagnosed in women in the Western world, remains unidentified, despite intensive investigations (1). Chemical compounds 4 To whom correspondence should be addressed such as the polycyclic aromatic hydrocarbons benzo [a] pyrene Microsatellite instability (MSI) and loss of heterozygosity (B[a]P*) and 7,12-dimethylbenz[a]anthracene (DMBA) are (LOH) in chromosomes 9 and 16 have been reported in known to be carcinogenic in experimental animal models human breast cancers. In order to determine whether (2-5); they have also been implicated to be of etiologic changes in these chromosomes play a role in the initiation importance in various human cancers (6). Since genomic and progression of this disease, we performed microsatellite instability, which has been well documented in colonic cancer polymorphism analyses in human breast epithelial cells (7), has also been considered to be involved in the evolution (HBEC) transformed by chemical carcinogens, an in vitro of breast cancer, from precursor lesions to metastatic cancer system that recapitulates various stages of neoplastic trans-(8-11), we performed microsatellite polymorphism analyses formation. In this experimental system we studied the in an in vitro system in which human breast epithelial cells
mortal HBEC MCF-10M, immortal MCF-10F cells, derived (HBEC) transformed by chemical carcinogens recapitulate from MCF-10M cells, and clones derived from MCF-10F
various stages of neoplastic transformation (12, 13 (12) (13) (14) (15) (16) (17) . Genotypic alterations were observed in the BP1-E cells induced the formation of tumors, designated immortalization of MCF-10F cells, which exhibited a point BP1E-Tp cells. These cells originated six additional tumors, mutation in exon 7 of the tumor suppressor gene p53 (14) . designated BP1E-Tf no. 1 through Tf no. 6. Microsatellite
The expression of colony formation in agar methocel and analyses were carried out using five markers for chromoanchorage independence were both associated with loss of some 9 and 20 for chromosome 16. There was no evidence heterozygosity (LOH) and point mutations in codons 12 and of MSI or LOH in clones BP1 and BP1E when compared 61 of the c-Ha-ras gene (15) . These early stages of expression with the MCF-10M and MCF-10F cells, whereas BP1E-Tp of cell transformation were accompanied by amplification of cells and Bp1E-Tf no. 1ϪTf no. 6 tumors exhibited MSI c-neu and c-myc oncogenes and rearrangement of int-2 (16). at loci p23 and p21, and LOH at p21Ϫ22 of chromosome
The expression of the tumorigenic phenotype was associated 9. They also exhibited MSI and LOH at multiple loci of with LOH in the telomeric portion of chromosome 17, and both the short and long arms of chromosome 16, i.e. p13.13, overexpression of the mdm2 gene (17). p13.3, p12, q12.1, q12.2, q23 and q24, to which putative Since microsatellite instability in chromosome 16q has tumor suppressor genes have been localized. Clones D3 been detected in atypical ductal hyperplasia (ADH), which is and D3-1 exhibited no genomic changes in chromosome 9, considered to be a precursor lesion (8-11), in a frequency but did show MSI at locus q12.1 of chromosome 16 using similar to that found in high and low nuclear grade ductal marker D16S285. Although the cells treated with DMBA carcinoma in situ (DCIS) and invasive carcinoma (18, 19) , and expressed early phenotypes of neoplastic transformation, in addition, LOH on the long arm of chromosome 16 has been they were not tumorigenic, and also manifested fewer found to be correlated with the occurrence of distant metastases changes than the tumorigenic BP1E-Tp cells and the tumors (20,21), we selected this chromosome for analysis in our BP1E-Tf. The changes in chromosomes 9 and 16 observed in vitro system. Another chromosome reported to exhibit in these latter ones indicated an association with the breakpoints and deletions in breast cancer is the chromosome expression of tumorigenesis, which represents a late event 9, on which the tumor suppressor gene cyclin dependent in the progression of the neoplastic transformation of kinase-4 inhibitor CDKN2 (MTSI/p16) has been mapped to HBEC. Of interest was the observation that HBEC translocus p21 (22) . Although primary tumors and cultured breast epithelial cells (22, 23) . Collectively, these data indicate that no direct relationship can be demonstrated between the histopathological characteristics of a breast lesion and the genetic changes observed (18,24,25). Thus, our in vitro system provides a unique model in which a mortal human breast epithelial cell can be compared with its derived immortal cell line, and with the clones derived from chemically transformed cells (12, 13, 26, 27) . We have used this model for determining whether the expression of phenotypes indicative of neoplastic initiation and progression are associated with the induction of specific genomic alterations in chromosomes 9 and 16. For these purposes we analyzed for LOH and MSI chromosomes 9 and 16 in the mortal cells MCF-10M, in its derived immortal MCF-10F cells (26, 27) , and in clones derived from MCF-10F cells treated with the chemical carcinogens BP (BP1 and BP1-E) and DMBA (D3 and D3-1). Of the four clones of transformed cells injected into severe combined immunodeficient (SCID) mice, only BP1-E cells induced the formation of tumors, BP1E-Tf no. 1 through Tf no. 6, which were also analyzed with the same markers.
Culture Collection (ATCC) (Rockville, MD) and at the 130th passage of a line maintained in our laboratory, BP1 cells at passages 27 and 52, BP1E cells at passages 23 and 60, BP1E-Tp cells at passage 6, BP1E-Tf no. 1, For extracting high molecular weight DNA, cells were lysed in 10 ml of TNE the chemical carcinogens BP and DMBA gave rise to clones BP1 and BP1E, (20 mM TrisϪHCl, pH 8.0, 100 mM NaCl, 25 mM EDTA) with 500 mg/ml and D3 and D3-1, respectively (12,13). The tumorigenic potential of the four of proteinase K and 1% sodium dodecyl sulfate (SDS), and incubated at 55°C clones of transformed cells was tested by inoculation into SCID mice. Only overnight with constant gentle agitation. Following two extractions with BP1E cells at passage 22, when inoculated into SCID mice gave origin to a phenol:chloroform (1:1 volume), the aqueous layer was adjusted to 0.75 M tumor after 101 days of injection; it was designated BP1E-Tp, which originated ammonium acetate, and DNA was spooled from two volumes of 100% the BP1E-Tp cell line. BP1E-Tp cells in their 20th passage were injected into ethanol, washed extensively in 70% ethanol, air dried and resuspended in TE six 35-45-day-old female virgin SCID mice (10ϫ10 6 cells/animal) in the buffer (10 mM TrisϪHCl, pH 8.0, 1 mM EDTA). right thoracic mammary gland. Six mammary carcinomas developed; they
Materials and methods
Microsatellite instability and loss of heterozygosity analysis were designated BP1E-Tf no. 1 through no. 6 (Figure 1 ). Bp1E-Tf tumors had a shorter latency (7 days) as well as a shorter period (21 days) to reach Polymerase chain reaction (PCR) was performed using primer sets obtained from Research Genetics (Huntsville, AL) or generously provided by Dr a diameter of 2 cm than the BP1E-Tp tumor (12) , indicating that these tumors exhibited a more aggressive behavior, and thus would represent a more A.Godwin (Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA). Five polymorphic microsatellite markers for chromosome advanced stage in the process of neoplastic progression. DNA was isolated from the following cell lines and tumors: MCF-10M cells at passages 22 and 9 and 20 for chromosome 16 were analyzed (Figures 2 and 3) . PCR was performed using 40 ng of template DNA, 5 µM of each paired primer, 1ϫ 29, MCF-10F cells obtained at their 85th passage from the American Type Taq buffer (PerkinϪElmer, NJ) in addition to 0.1 µCi/reaction of [α-33 P]dCTP (3000 Ci/mM) (Dupont/New Engalnd Nuclear, Boston, MA) in a total volume of 5 µl. The PCR reaction consisted of an initial denaturation step, followed by 35 cycles at 94°C for 40 s, the appropriate annealing temperature for 30 s, and 72°C for 30 s, extended at 72°C for 3 min. Each PCR reaction product was diluted 1:1 with loading buffer (95% formamide, 10 mM EDTA, pH 8.0, 0.1% xylene cyanol (w/v) and denatured at 95°C for 5 min. A 4 µl aliquot was loaded and electrophoresed on a 6% polyacrylamide gel at 60 W for 2 h. The gels were dried and exposed to Kodak X-omat-AR film (Eastman Kodak Co., Rochester, NY) at Ϫ80°C with intensifying screens. The presence of LOH and MSI was evaluated depending upon detection of a loss and/or a shift or expansion of electrophoretic bands (28) (29) (30) where the intensity of a signal in one allele was diminished approximately one half or more of its normal intensity in relation to the remaining alleles (23).
Results

Chromosome 9
Of all the cell lines and clones tested, MCF-10F, BP1, BP1E, D3 and D3-1 cells did not exhibit any changes when compared with their parental cell line MCF-10M with any of the markers analyzed in this study (Figure 2 ). DNA obtained from BP1E-Tp cells and BP1E-Tf no. 1, 2, 3, 4, 5 and 6 tumors showed MSI at loci 9p23, 9p21 and LOH at locus 9p21-22 of chromosome 9 when tested with microsatellite markers D9S199, D9S171 and D9S157, but did not show any changes with microsatellite markers D9S169 and D9S165 (Figures 2  and 4 ). These observations led us to conclude that MSI and LOH occurring in the telomeric portion of the short arm of chromosome 9 were late events in carcinogenesis, since those 
Chromosome 16
When tested for LOH and MSI utilizing 10 microsatellite markers for the short arm and 10 for the long arm of chromosome 16, no changes were detected in MCF-10F, BP1 and BP1E cells when compared with their parental cell line MCF-10M (Figure 3 ). D3 and D3-1 cells showed MSI at the 16q12.1 locus using marker D16S285 (Figures 3 and 5) . DNA obtained from BP1E-Tp cells and BP1E-Tf no. 1 through to Tf no. 6 tumors showed LOH and MSI at various loci of chromosome 16. The short arm of chromosome 16 showed MSI and/or LOH at loci p13.13 (D16S423, D16S404), p13.3 (D16S418), p13.1 (D16S405) and p12 (D16S420, D16S541) (Figure 3) . The long arm of chromosome 16 showed MSI and/ or LOH at loci q12.1 (D16S415), q12.2 (D16S389), q21 (D16S265), q22 (D16S398), q23 (D16S395) and q24 (D16S422, D16S449, D16S305) (Figure 3 ). LOH and MSI were detected more frequently in the telomeric regions of both the short and long arms of chromosome 16.
Since PCR amplification can sometimes generate spurious four passages from each cell line in this model were used to reduce the risk of PCR artifact and technical mishap. LOH breast epithelial cells, also induce LOH and MSI in the and MSI detected in multiple tumors induced by BP1E-Tp telomeric portions of the short arm of chromosome 9 and in cells were consistent with those found in tumor induced by both the short and long arms of chromosome 16. The largest BP1E cells in SCID mice, which confirmed the integrity of number of genomic alterations occurred in cells expressing biological tumor development, thus allowing us to rule out the the most advanced stages of neoplastic transformation, i.e. possibility of having detected random genetic alterations. tumorigenesis in a heterologous host. (38) , BP1E-Tf no. 1Ϫno. 6. This region is of interest since a breakpoint at the 16q12.1 locus and two break reciprocal and in the human breast epithelial cell line 184A1, which has been immortalized by treatment with B[a]P (23). In our translocations between chromosomes 5 and 16 have been described in association with the TownesϪBrock syndrome experimental system, however, LOH involving p21-22 locus was detected as a late phenomenon, associated with the (TBS), a rare autosomal dominant entity characterized by developmental abnormalities (60) . expression of the tumorigenic phenotype, since clones BP-1 and BP1E, which were not tumorigenic, did not exhibit either Human breast cancer is a diverse disease that presents with a broad spectrum of clinical and pathological characteristics. LOH or MSI with any of the markers tested. The finding that BP induced LOH at loci 9p21-22 suggests that the tumor These diverse characteristics may be a reflection of the multiplicity and heterogeneity of the molecular mechanisms suppressor gene located in that area, found to be involved in breast, lung and ovarian neoplasms (39,40), might also be involved in its genesis and progression. The detection of LOH and MSI on both chromosomes 9 and 16 in human breast affected by this chemical carcinogen.
Our findings indicate that human breast epithelial cells epithelial cells transformed with chemical carcinogens in vitro in the same regions found in primary breast cancers gives transformed with a chemical carcinogen in vitro exhibit multiple sites of LOH and MSI in both the short and the long relevance to this model, suggesting that it provides an adequate experimental system for testing the functionality of these arms of chromosome 16 which coincide with the genomic alterations most frequently reported in human breast carcinputative tumor suppressor genes in the initiation and progression of breast cancer. omas (41,42). We detected MSI at locus p13.3 of chromosome 16 in the DNA of BP1E-Tp cells and in the six BP1E-Tf no. 1Ϫno. 6 tumors, in a region in which an excision repair gene
